FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Alkem Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539523 NSE Symbol: ALKEM P/E (TTM) :27.74
ISIN Demat:INE540L01014 Div & Yield %:0.93 EPS (TTM) :174.78
Book Value (RS) :1030.5551792 Market Cap (Rs Cr.):57966.31 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 2,044.94 2,365.37 -13.55
Other Income 162.65 83.79 94.12
PBIDT 459.44 478.79 -4.04
Interest 16.91 20.68 -18.23
PBDT 442.53 458.11 -3.40
Depreciation 91.64 69.10 32.62
PBT 350.89 389.01 -9.80
Tax 36.75 77.41 -52.53
Deferred Tax 37.20 -13.37 0.00
PAT 276.94 324.97 -14.78

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)